Atherosclerosis Drugs Market Witnesses Surge in R&D Funding Amid Global Efforts to Combat Cardiovascular Diseases
The atherosclerosis drugs market is experiencing a notable surge in research and development (R&D) funding, driven by global efforts to combat the growing burden of cardiovascular diseases. As one of the leading causes of death worldwide, atherosclerosis characterized by plaque buildup in the arteries has prompted governments, healthcare organizations, and pharmaceutical companies to...
0
0
58